​

Astrana Health (ASTH) Stock Forecast, Price Target & Predictions

OverviewRevenueFinancialsChartTranscripts

ASTH Stock Forecast

Astrana Health (ASTH) stock forecast, based on 9 Wall Street analysts, predicts a 12-month average price target of $32.75, with a high of $40.00 and a low of $26.00. This represents a 35.00% increase from the last price of $24.26.

$20 $28 $36 $44 $52 $60 High: $40 Avg: $32.75 Low: $26 Last Closed Price: $24.26

ASTH Stock Rating

Astrana Health stock's rating consensus is Buy, based on 9 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 8 Buy (88.89%), 1 Hold (11.11%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 9 0 1 8 Strong Sell Sell Hold Buy Strong Buy

ASTH Price Target Upside V Benchmarks

TypeNameUpside
StockAstrana Health35.00%
SectorHealthcare Stocks 15.45%
IndustryMedical Care Facilities Stocks20.85%

Price Target Trends

1M3M12M
# Anlaysts-15
Avg Price Target-$40.00$33.40
Last Closing Price$24.26$24.26$24.26
Upside/Downside-64.88%37.68%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 26182--11
Feb, 26182--11
Jan, 26182--11
Dec, 25-82--10
Nov, 25-82--10
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 02, 2026BTIG$40.00$22.7475.90%64.88%
Dec 12, 2025Matthew SheaNeedham$28.00$22.4624.67%15.42%
Nov 25, 2025Jefferies$37.00$22.9161.50%52.51%
Nov 24, 2025Andrew MokBarclays$26.00$22.5015.56%7.17%
Apr 01, 2025Barclays$36.00$29.8620.56%48.39%
Mar 03, 2025Robert W. Baird$50.00$26.4888.82%106.10%
Oct 03, 2024David LarsenBTIG$70.00$57.8720.96%188.54%
Aug 15, 2024Michael HaRobert W. Baird$67.00$46.5843.84%176.17%
Jun 27, 2024Chris O'CullStifel Nicolaus$48.00$40.5018.52%97.86%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 12, 2025NeedhamBuyinitialise
Nov 25, 2025JefferiesBuyBuyhold
Oct 14, 2024Cowen & Co.Buyinitialise
Oct 10, 2024KeyBancSector Weightinitialise
Oct 03, 2024BTIGBuyBuyhold
Jul 11, 2024GuggenheimNeutralNeutralhold

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.57$1.00$1.30$0.91$0.46---
Avg Forecast$1.59$1.05$1.18$1.14$1.44$1.98$2.40$2.99
High Forecast$1.74$1.18$1.32$1.22$1.68$2.27$2.68$3.34
Low Forecast$1.50$0.94$1.04$1.07$1.20$1.56$2.11$2.63
Surprise %-1.26%-4.76%10.17%-20.18%-68.06%---

Revenue Forecast

$500M $1B $2B $3B $4B $5B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$773.91M$1.14B$1.39B$2.03B$3.18B---
Avg Forecast$755.06M$1.10B$1.37B$1.97B$2.57B$3.04B$3.32B$3.71B
High Forecast$810.80M$1.21B$1.38B$2.01B$2.67B$3.10B$3.62B$4.04B
Low Forecast$722.00M$1.01B$1.37B$1.95B$2.40B$2.97B$3.01B$3.37B
Surprise %2.50%4.27%0.86%3.27%23.59%---

Net Income Forecast

$0 $40M $80M $120M $160M $200M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$68.92M$45.17M$60.72M$43.15M$22.49M---
Avg Forecast$74.64M$49.19M$60.72M$53.91M$70.29M$94.48M$120.50M$140.73M
High Forecast$81.80M$55.71M$62.07M$57.63M$79.20M$106.62M$126.22M$157.25M
Low Forecast$70.39M$44.17M$48.91M$50.20M$56.64M$73.63M$99.47M$123.92M
Surprise %-7.66%-8.16%--19.97%-68.01%---

ASTH Forecast FAQ

Is Astrana Health stock a buy?

Astrana Health stock has a consensus rating of Buy, based on 9 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 8 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Astrana Health is a favorable investment for most analysts.

What is Astrana Health's price target?

Astrana Health's price target, set by 9 Wall Street analysts, averages $32.75 over the next 12 months. The price target range spans from $26 at the low end to $40 at the high end, suggesting a potential 35.00% change from the previous closing price of $24.26.

How does Astrana Health stock forecast compare to its benchmarks?

Astrana Health's stock forecast shows a 35.00% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical care facilities stocks industry (20.85%).

What is the breakdown of analyst ratings for Astrana Health over the past three months?

  • March 2026: 9.09% Strong Buy, 72.73% Buy, 18.18% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 9.09% Strong Buy, 72.73% Buy, 18.18% Hold, 0% Sell, 0% Strong Sell.
  • January 2026: 9.09% Strong Buy, 72.73% Buy, 18.18% Hold, 0% Sell, 0% Strong Sell.

What is Astrana Health’s EPS forecast?

Astrana Health's average annual EPS forecast for its fiscal year ending in December 2026 is $1.98, marking a 330.43% increase from the reported $0.46 in 2025. Estimates for the following years are $2.4 in 2027, and $2.99 in 2028.

What is Astrana Health’s revenue forecast?

Astrana Health's average annual revenue forecast for its fiscal year ending in December 2026 is $3.04B, reflecting a -4.52% decrease from the reported $3.18B in 2025. The forecast for 2027 is $3.32B, and $3.71B for 2028.

What is Astrana Health’s net income forecast?

Astrana Health's net income forecast for the fiscal year ending in December 2026 stands at $94.48M, representing an 320.17% increase from the reported $22.49M in 2025. Projections indicate $120.5M in 2027, and $140.73M in 2028.